Mesenchymal Stem Cells for the Treatment of MS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00781872

Recruitment Status : Completed

First Posted : October 29, 2008

Last Update Posted : June 13, 2019

Sponsor:

Information provided by (Responsible Party):

Dimitrios Karussis, Hadassah Medical Organization

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	December 2009
Actual Study Completion Date :	December 2009

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, Gomori JM, Kassis I, Bulte JW, Petrou P, Ben-Hur T, Abramsky O, Slavin S. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol. 2010 Oct;67(10):1187-94. doi: 10.1001/archneurol.2010.248.

To Top